Nektar Therapeutics (NKTR) PT Raised to $95 at Wedbush
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $75.92 --0%
Rating Summary:
20 Buy, 7 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 9
Rating Summary:
20 Buy, 7 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 9
Join SI Premium – FREE
Wedbush analyst Martin Fan raised the price target on Nektar Therapeutics (NASDAQ: NKTR) to $95.00 (from $70.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bullish (BLSH) PT Raised to $30 at Compass Point
- Lake Street Downgrades SoundThinking (SSTI) to Hold
- HeartFlow (HTFL) PT Raised to $45 at Stifel as Plaque Business Revenue Ramps
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
